Genome engineering using the CRISPR-Cas9 system
- PMID: 24157548
- PMCID: PMC3969860
- DOI: 10.1038/nprot.2013.143
Genome engineering using the CRISPR-Cas9 system
Abstract
Targeted nucleases are powerful tools for mediating genome alteration with high precision. The RNA-guided Cas9 nuclease from the microbial clustered regularly interspaced short palindromic repeats (CRISPR) adaptive immune system can be used to facilitate efficient genome engineering in eukaryotic cells by simply specifying a 20-nt targeting sequence within its guide RNA. Here we describe a set of tools for Cas9-mediated genome editing via nonhomologous end joining (NHEJ) or homology-directed repair (HDR) in mammalian cells, as well as generation of modified cell lines for downstream functional studies. To minimize off-target cleavage, we further describe a double-nicking strategy using the Cas9 nickase mutant with paired guide RNAs. This protocol provides experimentally derived guidelines for the selection of target sites, evaluation of cleavage efficiency and analysis of off-target activity. Beginning with target design, gene modifications can be achieved within as little as 1-2 weeks, and modified clonal cell lines can be derived within 2-3 weeks.
Figures
Similar articles
-
Genome editing using Cas9 nickases.Methods Enzymol. 2014;546:161-74. doi: 10.1016/B978-0-12-801185-0.00008-8. Methods Enzymol. 2014. PMID: 25398340
-
Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery.Elife. 2014 Dec 15;3:e04766. doi: 10.7554/eLife.04766. Elife. 2014. PMID: 25497837 Free PMC article.
-
Optimization of genome engineering approaches with the CRISPR/Cas9 system.PLoS One. 2014 Aug 28;9(8):e105779. doi: 10.1371/journal.pone.0105779. eCollection 2014. PLoS One. 2014. PMID: 25166277 Free PMC article.
-
Application of CRISPR/Cas9 genome editing to the study and treatment of disease.Arch Toxicol. 2015 Jul;89(7):1023-34. doi: 10.1007/s00204-015-1504-y. Epub 2015 Apr 1. Arch Toxicol. 2015. PMID: 25827103 Review.
-
Optimization of genome editing through CRISPR-Cas9 engineering.Bioengineered. 2016 Apr;7(3):166-74. doi: 10.1080/21655979.2016.1189039. Bioengineered. 2016. PMID: 27340770 Free PMC article. Review.
Cited by 2,818 articles
-
Rapid repair of human disease-specific single-nucleotide variants by One-SHOT genome editing.Sci Rep. 2020 Aug 18;10(1):13927. doi: 10.1038/s41598-020-70401-7. Sci Rep. 2020. PMID: 32811847 Free PMC article.
-
Acute Myeloid Leukemia Chemo-Resistance Is Mediated by E-selectin Receptor CD162 in Bone Marrow Niches.Front Cell Dev Biol. 2020 Jul 24;8:668. doi: 10.3389/fcell.2020.00668. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32793603 Free PMC article.
-
Elucidating the fundamental fibrotic processes driving abdominal adhesion formation.Nat Commun. 2020 Aug 13;11(1):4061. doi: 10.1038/s41467-020-17883-1. Nat Commun. 2020. PMID: 32792541 Free PMC article.
-
A novel N6-methyladenosine (m6A)-dependent fate decision for the lncRNA THOR.Cell Death Dis. 2020 Aug 13;11(8):613. doi: 10.1038/s41419-020-02833-y. Cell Death Dis. 2020. PMID: 32792482 Free PMC article.
-
Evaluation of the upregulation and surface expression of hypoxanthine guanine phosphoribosyltransferase in acute lymphoblastic leukemia and Burkitt's B cell lymphoma.Cancer Cell Int. 2020 Aug 6;20:375. doi: 10.1186/s12935-020-01457-8. eCollection 2020. Cancer Cell Int. 2020. PMID: 32782434 Free PMC article.
Publication types
MeSH terms
Substances
Grant support
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources
-
Research Materials